EPISODIC MIGRAINE

This study tests whether eptinezumab, given as an IV infusion, can prevent migraines in children aged 6 to 17 with episodic migraine. About 315 participants will receive either the drug or a placebo. The main goal is to see if the drug reduces the number of migraine days per mont…

This study tests whether atorvastatin, a drug usually used for cholesterol, can help prevent migraine attacks in people with episodic migraine. Researchers will compare a 40 mg dose, a 20 mg dose, and a placebo in 450 adults aged 18–65. The goal is to see if the drug reduces the …

This study is checking the safety and effectiveness of atogepant, a drug already approved for migraine prevention, in Korean adults with chronic or episodic migraines. About 3000 people whose doctors prescribe atogepant will take the pill as usual and be followed for up to 12 wee…

This study tests whether Xeomin injections into head and neck muscles can prevent episodic migraines. About 990 adults with frequent migraines will receive either Xeomin or a placebo every 12 weeks for a year. The main goal is to see if Xeomin reduces the number of migraine days …

This study tests whether atogepant, a drug already approved for adults, can safely prevent migraines in children aged 6 to 17. About 450 participants will take a daily tablet (low dose, high dose, or placebo) for 12 weeks. The goal is to reduce the number of migraine days each mo…

This study tests an injection called IPN10200 to prevent migraines in adults with episodic or chronic migraine. The drug works by blocking pain-causing chemicals in the brain. About 641 participants will receive either the drug or a placebo to find the safest and most effective d…

This study tests whether injecting a numbing medication and a steroid into the scalp nerves can stop a migraine in its tracks and prevent future ones for months. Researchers will enroll 60 people who get 4 to 14 migraines per month. The goal is to see if this nerve block can elim…

This study follows 700 people with migraine who are taking newer preventive drugs (anti-CGRP medications) to see how well they work in everyday life. Researchers will track changes in monthly headache days and migraine impact over two years. The goal is to understand real-world b…

This study tests whether Gou-Teng-San (GTS), a traditional herbal medicine, can safely reduce migraine frequency and symptoms in adults with episodic migraine. About 40 participants will be randomly assigned to receive GTS or a placebo, and researchers will track changes in month…